Drug trial helps woman cheat death for five years
by Karen Stamm
Five years later, Boone is still alive, and a patient of Dr. Monica Mita. The drug that stabilized her cancer is known as Agent AP23573, which regulates normal cell growth and slows or stops the growth of cancer cells. The drug has progressed to the third of four phases of testing.
"Carolyn Booneís story is an inspiration for other patients and care providers," Dr. Mita said. "Her experience is what we would like to see for all patients with advanced cancer - significant and durable response with a normal quality of life."
How to enroll in a clinical study
During the past five years, more than 3,000 patients have been treated in new drug studies at the CTRC at the UT Health Science Center San Antonio. For some patients, these treatments offer hope, when before, there was none.
To learn about enrolling in a clinical study, contact the CTRCís Clinical Studies Referral Office.
Phone: (210) 450-5798
Fax: (210) 616-5844
UT Health Science Center
© 2002 - 2013 UTHSCSA
Links provided from UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.